Our unpublished data suggest that GLI2 functions as a downstream target of TGF-β/Smad3 in poorly differentiated hepatoma cells (Cancer Res 2020; 80 (16 Supplement): DOI: 10.1158/1538-7445.AM2020-6336). The gene discussed is GLI2; the disease is hepatocellular carcinoma.